Trial Profile
A Comparative Study of JTT-751 with Sodium Ferrous Citrate in Patients with Iron Deficiency Anemia
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 14 Dec 2021
Price :
$35
*
At a glance
- Drugs Ferric citrate (Primary) ; Sodium ferrous citrate
- Indications Iron deficiency anaemia
- Focus Registrational; Therapeutic Use
- Sponsors Japan Tobacco
- 01 Jul 2021 Status changed from active, no longer recruiting to completed, as per Results published in the International Journal of Hematology
- 01 Jul 2021 Results published in the International Journal of Hematology
- 24 Mar 2021 According to an Akebia Therapeutics media release, Japan Tobacco received approval from the Pharmaceuticals and Medical Devices Agency (PMDA) for an additional indication for Riona Tablets 250mg (Riona) ( ferric citrate hydrate) to treat adult patients with iron deficiency anemia (IDA) in Japan.